Tolerability of inhalation of salt particles in COPD patients

U. Møller Weinreich (Ålborg, Denmark), S. Dyrman Nielsen (Ålborg, Denmark)

Source: Virtual Congress 2020 – Burden and predictive factors for chronic lung diseases and comorbidity
Session: Burden and predictive factors for chronic lung diseases and comorbidity
Session type: E-poster session
Number: 2987
Disease area: Airway diseases

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
U. Møller Weinreich (Ålborg, Denmark), S. Dyrman Nielsen (Ålborg, Denmark). Tolerability of inhalation of salt particles in COPD patients. 2987

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Oral and inhalation usage of acetylcysteine in patients with COPD
Source: International Congress 2019 – Advances in COPD pharmacology
Year: 2019


Efficacy of tiotropium bromide inhalation combined with or without low dose theophylline for moderate to severe stable Chinese COPD patients
Source: Annual Congress 2013 –Asthma and COPD drugs: efficacy, safety and pharmacoeconomics
Year: 2013

Safety and pharmacokinetics of multiple-dose ciprofloxacin dry powder for inhalation in patients with moderate or severe COPD
Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Year: 2011

Long-term safety of inhaled formoterol in patients with COPD
Source: Annual Congress 2009 - Drug effects in COPD
Year: 2009

The pharmacokinetics of inhaled NVA237 in COPD patients
Source: Annual Congress 2010 - Drug delivery and pharmacokinetics II
Year: 2010

Efficacy and safety of single doses of inhaled LAS100977 in patients with mild to moderate asthma
Source: Annual Congress 2010 - Combination therapy in asthma and COPD
Year: 2010


Efficacy of budesonide inhalation suspension in acute exacerbation of bronchial asthma in adults
Source: Eur Respir J 2006; 28: Suppl. 50, 500s
Year: 2006

Bronchodilator efficacy of tiotropium in patients with mild COPD
Source: Eur Respir J 2006; 28: Suppl. 50, 616s
Year: 2006

A comparison of tiotropium inhalation capsules and ipratropium metered dose inhaler in a double-blind, efficacy and safety study in Chinese adults with chronic obstructive pulmonary disease (COPD)
Source: Eur Respir J 2006; 28: Suppl. 50, 213s
Year: 2006

Efficacy of inhalation from different powder inhalators in COPD patiens with chronic respiratory failure
Source: Eur Respir J 2006; 28: Suppl. 50, 210s
Year: 2006

Effect of inhaled tiotropium on tracheobronchial clearance in patients with COPD
Source: Eur Respir J 2001; 18: Suppl. 33, 245s
Year: 2001

Safety, dose finding and efficacy of ectoine inhalation solution in patients with mild asthma
Source: Annual Congress 2010 - New treatments for asthma and COPD
Year: 2010

Clinical efficacy of nebulised budesonide in acute exacerbation of COPD
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010

Safety and pharmacokinetics of two dose strengths of ciprofloxacin dry powder for inhalation (DPI) in patients with moderate to severe COPD
Source: Annual Congress 2012 - Hot topics in respiratory infections
Year: 2012



Evaluation of the efficacy and safety of two formulations of Ipratropium bromide HFA pMDI in patients with mild to moderate chronic obstructive pulmonary disease (COPD)
Source: Annual Congress 2010 - COPD: treatment and monitoring
Year: 2010

Efficacy and safety of nebulized glycopyrrolate (EP-101) for administration using high efficiency nebulizer in patients with COPD
Source: Annual Congress 2011 - Bronchodilators in asthma and COPD
Year: 2011

Efficacy and safety of intravenous montelukast in patients with acute exacerbations of bronchial asthma
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008


Adhesion to inhaled treatment in patients with asthma and COPD
Source: Virtual Congress 2020 – Inhaled corticosteroids and bronchodilator studies in asthma
Year: 2020


Efficacy and safety of AZD3199, an inhaled ultra long-acting β2-agonist, in patients with COPD
Source: Annual Congress 2011 - Bronchodilators in asthma and COPD
Year: 2011